nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—KCNE1—gonad—testicular cancer	0.0162	0.172	CbGeAlD
Indapamide—KCNE1—testis—testicular cancer	0.0117	0.124	CbGeAlD
Indapamide—KCNQ1—seminal vesicle—testicular cancer	0.0103	0.11	CbGeAlD
Indapamide—KCNQ1—female gonad—testicular cancer	0.00603	0.0643	CbGeAlD
Indapamide—KCNQ1—testis—testicular cancer	0.00535	0.057	CbGeAlD
Indapamide—CA9—testis—testicular cancer	0.00516	0.055	CbGeAlD
Indapamide—CA5B—gonad—testicular cancer	0.00475	0.0506	CbGeAlD
Indapamide—CA4—seminal vesicle—testicular cancer	0.00454	0.0484	CbGeAlD
Indapamide—CA2—embryo—testicular cancer	0.00401	0.0427	CbGeAlD
Indapamide—KCNQ1—lymph node—testicular cancer	0.00388	0.0413	CbGeAlD
Indapamide—CA2—seminal vesicle—testicular cancer	0.00376	0.0401	CbGeAlD
Indapamide—CA5B—testis—testicular cancer	0.00342	0.0365	CbGeAlD
Indapamide—CA4—female gonad—testicular cancer	0.00266	0.0284	CbGeAlD
Indapamide—CA5B—lymph node—testicular cancer	0.00248	0.0265	CbGeAlD
Indapamide—CA4—testis—testicular cancer	0.00236	0.0252	CbGeAlD
Indapamide—CA2—female gonad—testicular cancer	0.00221	0.0236	CbGeAlD
Indapamide—CA2—testis—testicular cancer	0.00196	0.0209	CbGeAlD
Indapamide—CA4—lymph node—testicular cancer	0.00171	0.0183	CbGeAlD
Indapamide—CA2—lymph node—testicular cancer	0.00142	0.0151	CbGeAlD
Indapamide—Hepatobiliary disease—Epirubicin—testicular cancer	0.000626	0.000691	CcSEcCtD
Indapamide—Urethral disorder—Methotrexate—testicular cancer	0.000623	0.000687	CcSEcCtD
Indapamide—Weight decreased—Doxorubicin—testicular cancer	0.000622	0.000686	CcSEcCtD
Indapamide—Sinusitis—Epirubicin—testicular cancer	0.000621	0.000686	CcSEcCtD
Indapamide—Feeling abnormal—Etoposide—testicular cancer	0.000621	0.000685	CcSEcCtD
Indapamide—Hyperglycaemia—Doxorubicin—testicular cancer	0.00062	0.000684	CcSEcCtD
Indapamide—Nausea—Dactinomycin—testicular cancer	0.000619	0.000683	CcSEcCtD
Indapamide—Agranulocytosis—Epirubicin—testicular cancer	0.000618	0.000682	CcSEcCtD
Indapamide—Pneumonia—Doxorubicin—testicular cancer	0.000616	0.00068	CcSEcCtD
Indapamide—Gastrointestinal pain—Etoposide—testicular cancer	0.000616	0.00068	CcSEcCtD
Indapamide—Drowsiness—Doxorubicin—testicular cancer	0.000613	0.000676	CcSEcCtD
Indapamide—Visual impairment—Methotrexate—testicular cancer	0.000612	0.000676	CcSEcCtD
Indapamide—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000608	0.000671	CcSEcCtD
Indapamide—Vomiting—Ifosfamide—testicular cancer	0.000607	0.00067	CcSEcCtD
Indapamide—Hypersensitivity—Cisplatin—testicular cancer	0.000606	0.000669	CcSEcCtD
Indapamide—Renal failure—Doxorubicin—testicular cancer	0.000602	0.000665	CcSEcCtD
Indapamide—Rash—Ifosfamide—testicular cancer	0.000602	0.000664	CcSEcCtD
Indapamide—Dermatitis—Ifosfamide—testicular cancer	0.000601	0.000663	CcSEcCtD
Indapamide—Erythema multiforme—Methotrexate—testicular cancer	0.000601	0.000663	CcSEcCtD
Indapamide—Urticaria—Etoposide—testicular cancer	0.000599	0.000661	CcSEcCtD
Indapamide—Jaundice—Doxorubicin—testicular cancer	0.000597	0.000659	CcSEcCtD
Indapamide—Stomatitis—Doxorubicin—testicular cancer	0.000597	0.000659	CcSEcCtD
Indapamide—Rhinitis—Epirubicin—testicular cancer	0.000596	0.000658	CcSEcCtD
Indapamide—Body temperature increased—Etoposide—testicular cancer	0.000596	0.000657	CcSEcCtD
Indapamide—Abdominal pain—Etoposide—testicular cancer	0.000596	0.000657	CcSEcCtD
Indapamide—Urinary tract infection—Doxorubicin—testicular cancer	0.000596	0.000657	CcSEcCtD
Indapamide—Conjunctivitis—Doxorubicin—testicular cancer	0.000596	0.000657	CcSEcCtD
Indapamide—Hepatitis—Epirubicin—testicular cancer	0.000595	0.000656	CcSEcCtD
Indapamide—Tinnitus—Methotrexate—testicular cancer	0.000592	0.000654	CcSEcCtD
Indapamide—Hypoaesthesia—Epirubicin—testicular cancer	0.000592	0.000653	CcSEcCtD
Indapamide—Asthenia—Cisplatin—testicular cancer	0.00059	0.000651	CcSEcCtD
Indapamide—Pharyngitis—Epirubicin—testicular cancer	0.00059	0.000651	CcSEcCtD
Indapamide—Cardiac disorder—Methotrexate—testicular cancer	0.00059	0.000651	CcSEcCtD
Indapamide—Sweating—Doxorubicin—testicular cancer	0.000588	0.000648	CcSEcCtD
Indapamide—Urinary tract disorder—Epirubicin—testicular cancer	0.000587	0.000648	CcSEcCtD
Indapamide—Oedema peripheral—Epirubicin—testicular cancer	0.000586	0.000646	CcSEcCtD
Indapamide—Urethral disorder—Epirubicin—testicular cancer	0.000583	0.000643	CcSEcCtD
Indapamide—Hepatobiliary disease—Doxorubicin—testicular cancer	0.00058	0.00064	CcSEcCtD
Indapamide—Sinusitis—Doxorubicin—testicular cancer	0.000575	0.000635	CcSEcCtD
Indapamide—Visual impairment—Epirubicin—testicular cancer	0.000573	0.000632	CcSEcCtD
Indapamide—Agranulocytosis—Doxorubicin—testicular cancer	0.000572	0.000631	CcSEcCtD
Indapamide—Nausea—Ifosfamide—testicular cancer	0.000567	0.000625	CcSEcCtD
Indapamide—Diarrhoea—Cisplatin—testicular cancer	0.000563	0.000621	CcSEcCtD
Indapamide—Erythema multiforme—Epirubicin—testicular cancer	0.000562	0.00062	CcSEcCtD
Indapamide—Hypersensitivity—Etoposide—testicular cancer	0.000555	0.000613	CcSEcCtD
Indapamide—Tinnitus—Epirubicin—testicular cancer	0.000554	0.000612	CcSEcCtD
Indapamide—Malnutrition—Methotrexate—testicular cancer	0.000553	0.00061	CcSEcCtD
Indapamide—Erythema—Methotrexate—testicular cancer	0.000553	0.00061	CcSEcCtD
Indapamide—Flushing—Epirubicin—testicular cancer	0.000552	0.000609	CcSEcCtD
Indapamide—Cardiac disorder—Epirubicin—testicular cancer	0.000552	0.000609	CcSEcCtD
Indapamide—Rhinitis—Doxorubicin—testicular cancer	0.000552	0.000609	CcSEcCtD
Indapamide—Hepatitis—Doxorubicin—testicular cancer	0.00055	0.000607	CcSEcCtD
Indapamide—Hypoaesthesia—Doxorubicin—testicular cancer	0.000547	0.000604	CcSEcCtD
Indapamide—Pharyngitis—Doxorubicin—testicular cancer	0.000546	0.000603	CcSEcCtD
Indapamide—Urinary tract disorder—Doxorubicin—testicular cancer	0.000543	0.0006	CcSEcCtD
Indapamide—Oedema peripheral—Doxorubicin—testicular cancer	0.000542	0.000598	CcSEcCtD
Indapamide—Dysgeusia—Methotrexate—testicular cancer	0.000542	0.000598	CcSEcCtD
Indapamide—Asthenia—Etoposide—testicular cancer	0.000541	0.000597	CcSEcCtD
Indapamide—Urethral disorder—Doxorubicin—testicular cancer	0.000539	0.000595	CcSEcCtD
Indapamide—Back pain—Methotrexate—testicular cancer	0.000535	0.00059	CcSEcCtD
Indapamide—Pruritus—Etoposide—testicular cancer	0.000533	0.000588	CcSEcCtD
Indapamide—Arrhythmia—Epirubicin—testicular cancer	0.000531	0.000586	CcSEcCtD
Indapamide—Visual impairment—Doxorubicin—testicular cancer	0.00053	0.000585	CcSEcCtD
Indapamide—Vomiting—Cisplatin—testicular cancer	0.000523	0.000577	CcSEcCtD
Indapamide—Vision blurred—Methotrexate—testicular cancer	0.000521	0.000575	CcSEcCtD
Indapamide—Erythema multiforme—Doxorubicin—testicular cancer	0.00052	0.000574	CcSEcCtD
Indapamide—Rash—Cisplatin—testicular cancer	0.000519	0.000572	CcSEcCtD
Indapamide—Dermatitis—Cisplatin—testicular cancer	0.000518	0.000572	CcSEcCtD
Indapamide—Malnutrition—Epirubicin—testicular cancer	0.000518	0.000571	CcSEcCtD
Indapamide—Erythema—Epirubicin—testicular cancer	0.000518	0.000571	CcSEcCtD
Indapamide—Diarrhoea—Etoposide—testicular cancer	0.000516	0.000569	CcSEcCtD
Indapamide—Ill-defined disorder—Methotrexate—testicular cancer	0.000513	0.000566	CcSEcCtD
Indapamide—Tinnitus—Doxorubicin—testicular cancer	0.000513	0.000566	CcSEcCtD
Indapamide—Anaemia—Methotrexate—testicular cancer	0.000511	0.000564	CcSEcCtD
Indapamide—Cardiac disorder—Doxorubicin—testicular cancer	0.000511	0.000563	CcSEcCtD
Indapamide—Flushing—Doxorubicin—testicular cancer	0.000511	0.000563	CcSEcCtD
Indapamide—Flatulence—Epirubicin—testicular cancer	0.00051	0.000563	CcSEcCtD
Indapamide—Tension—Epirubicin—testicular cancer	0.000508	0.000561	CcSEcCtD
Indapamide—Dysgeusia—Epirubicin—testicular cancer	0.000507	0.000559	CcSEcCtD
Indapamide—Nervousness—Epirubicin—testicular cancer	0.000503	0.000555	CcSEcCtD
Indapamide—Back pain—Epirubicin—testicular cancer	0.000501	0.000553	CcSEcCtD
Indapamide—Malaise—Methotrexate—testicular cancer	0.000499	0.00055	CcSEcCtD
Indapamide—Dizziness—Etoposide—testicular cancer	0.000498	0.00055	CcSEcCtD
Indapamide—Muscle spasms—Epirubicin—testicular cancer	0.000498	0.000549	CcSEcCtD
Indapamide—Vertigo—Methotrexate—testicular cancer	0.000497	0.000548	CcSEcCtD
Indapamide—Leukopenia—Methotrexate—testicular cancer	0.000495	0.000546	CcSEcCtD
Indapamide—Arrhythmia—Doxorubicin—testicular cancer	0.000492	0.000542	CcSEcCtD
Indapamide—Nausea—Cisplatin—testicular cancer	0.000489	0.000539	CcSEcCtD
Indapamide—Vision blurred—Epirubicin—testicular cancer	0.000488	0.000538	CcSEcCtD
Indapamide—Cough—Methotrexate—testicular cancer	0.000483	0.000533	CcSEcCtD
Indapamide—Ill-defined disorder—Epirubicin—testicular cancer	0.00048	0.00053	CcSEcCtD
Indapamide—Vomiting—Etoposide—testicular cancer	0.000479	0.000529	CcSEcCtD
Indapamide—Erythema—Doxorubicin—testicular cancer	0.000479	0.000529	CcSEcCtD
Indapamide—Malnutrition—Doxorubicin—testicular cancer	0.000479	0.000529	CcSEcCtD
Indapamide—Anaemia—Epirubicin—testicular cancer	0.000478	0.000528	CcSEcCtD
Indapamide—Agitation—Epirubicin—testicular cancer	0.000476	0.000525	CcSEcCtD
Indapamide—Rash—Etoposide—testicular cancer	0.000475	0.000524	CcSEcCtD
Indapamide—Dermatitis—Etoposide—testicular cancer	0.000475	0.000524	CcSEcCtD
Indapamide—Headache—Etoposide—testicular cancer	0.000472	0.000521	CcSEcCtD
Indapamide—Flatulence—Doxorubicin—testicular cancer	0.000472	0.000521	CcSEcCtD
Indapamide—Arthralgia—Methotrexate—testicular cancer	0.000471	0.00052	CcSEcCtD
Indapamide—Myalgia—Methotrexate—testicular cancer	0.000471	0.00052	CcSEcCtD
Indapamide—Chest pain—Methotrexate—testicular cancer	0.000471	0.00052	CcSEcCtD
Indapamide—Tension—Doxorubicin—testicular cancer	0.00047	0.000519	CcSEcCtD
Indapamide—Dysgeusia—Doxorubicin—testicular cancer	0.000469	0.000518	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000468	0.000516	CcSEcCtD
Indapamide—Malaise—Epirubicin—testicular cancer	0.000467	0.000515	CcSEcCtD
Indapamide—Discomfort—Methotrexate—testicular cancer	0.000465	0.000513	CcSEcCtD
Indapamide—Nervousness—Doxorubicin—testicular cancer	0.000465	0.000513	CcSEcCtD
Indapamide—Vertigo—Epirubicin—testicular cancer	0.000465	0.000513	CcSEcCtD
Indapamide—Syncope—Epirubicin—testicular cancer	0.000464	0.000512	CcSEcCtD
Indapamide—Leukopenia—Epirubicin—testicular cancer	0.000463	0.000511	CcSEcCtD
Indapamide—Back pain—Doxorubicin—testicular cancer	0.000463	0.000511	CcSEcCtD
Indapamide—Muscle spasms—Doxorubicin—testicular cancer	0.00046	0.000508	CcSEcCtD
Indapamide—Palpitations—Epirubicin—testicular cancer	0.000457	0.000505	CcSEcCtD
Indapamide—Loss of consciousness—Epirubicin—testicular cancer	0.000455	0.000502	CcSEcCtD
Indapamide—Cough—Epirubicin—testicular cancer	0.000452	0.000498	CcSEcCtD
Indapamide—Anaphylactic shock—Methotrexate—testicular cancer	0.000451	0.000498	CcSEcCtD
Indapamide—Vision blurred—Doxorubicin—testicular cancer	0.000451	0.000498	CcSEcCtD
Indapamide—Infection—Methotrexate—testicular cancer	0.000448	0.000495	CcSEcCtD
Indapamide—Nausea—Etoposide—testicular cancer	0.000448	0.000494	CcSEcCtD
Indapamide—Ill-defined disorder—Doxorubicin—testicular cancer	0.000444	0.00049	CcSEcCtD
Indapamide—Nervous system disorder—Methotrexate—testicular cancer	0.000443	0.000489	CcSEcCtD
Indapamide—Anaemia—Doxorubicin—testicular cancer	0.000443	0.000489	CcSEcCtD
Indapamide—Thrombocytopenia—Methotrexate—testicular cancer	0.000442	0.000488	CcSEcCtD
Indapamide—Myalgia—Epirubicin—testicular cancer	0.000441	0.000486	CcSEcCtD
Indapamide—Arthralgia—Epirubicin—testicular cancer	0.000441	0.000486	CcSEcCtD
Indapamide—Chest pain—Epirubicin—testicular cancer	0.000441	0.000486	CcSEcCtD
Indapamide—Agitation—Doxorubicin—testicular cancer	0.00044	0.000486	CcSEcCtD
Indapamide—Anxiety—Epirubicin—testicular cancer	0.000439	0.000485	CcSEcCtD
Indapamide—Skin disorder—Methotrexate—testicular cancer	0.000438	0.000484	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000438	0.000483	CcSEcCtD
Indapamide—Hyperhidrosis—Methotrexate—testicular cancer	0.000436	0.000482	CcSEcCtD
Indapamide—Discomfort—Epirubicin—testicular cancer	0.000435	0.00048	CcSEcCtD
Indapamide—Malaise—Doxorubicin—testicular cancer	0.000432	0.000477	CcSEcCtD
Indapamide—Dry mouth—Epirubicin—testicular cancer	0.000431	0.000476	CcSEcCtD
Indapamide—Vertigo—Doxorubicin—testicular cancer	0.00043	0.000475	CcSEcCtD
Indapamide—Anorexia—Methotrexate—testicular cancer	0.00043	0.000475	CcSEcCtD
Indapamide—Syncope—Doxorubicin—testicular cancer	0.00043	0.000474	CcSEcCtD
Indapamide—Leukopenia—Doxorubicin—testicular cancer	0.000429	0.000473	CcSEcCtD
Indapamide—Palpitations—Doxorubicin—testicular cancer	0.000423	0.000467	CcSEcCtD
Indapamide—Anaphylactic shock—Epirubicin—testicular cancer	0.000422	0.000466	CcSEcCtD
Indapamide—Oedema—Epirubicin—testicular cancer	0.000422	0.000466	CcSEcCtD
Indapamide—Hypotension—Methotrexate—testicular cancer	0.000422	0.000465	CcSEcCtD
Indapamide—Loss of consciousness—Doxorubicin—testicular cancer	0.000421	0.000465	CcSEcCtD
Indapamide—Infection—Epirubicin—testicular cancer	0.00042	0.000463	CcSEcCtD
Indapamide—Cough—Doxorubicin—testicular cancer	0.000418	0.000461	CcSEcCtD
Indapamide—Shock—Epirubicin—testicular cancer	0.000416	0.000459	CcSEcCtD
Indapamide—Nervous system disorder—Epirubicin—testicular cancer	0.000414	0.000457	CcSEcCtD
Indapamide—Thrombocytopenia—Epirubicin—testicular cancer	0.000414	0.000456	CcSEcCtD
Indapamide—Tachycardia—Epirubicin—testicular cancer	0.000412	0.000455	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000411	0.000454	CcSEcCtD
Indapamide—Skin disorder—Epirubicin—testicular cancer	0.00041	0.000453	CcSEcCtD
Indapamide—Hyperhidrosis—Epirubicin—testicular cancer	0.000408	0.000451	CcSEcCtD
Indapamide—Insomnia—Methotrexate—testicular cancer	0.000408	0.000451	CcSEcCtD
Indapamide—Myalgia—Doxorubicin—testicular cancer	0.000408	0.00045	CcSEcCtD
Indapamide—Arthralgia—Doxorubicin—testicular cancer	0.000408	0.00045	CcSEcCtD
Indapamide—Chest pain—Doxorubicin—testicular cancer	0.000408	0.00045	CcSEcCtD
Indapamide—Anxiety—Doxorubicin—testicular cancer	0.000406	0.000448	CcSEcCtD
Indapamide—Paraesthesia—Methotrexate—testicular cancer	0.000405	0.000447	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000405	0.000447	CcSEcCtD
Indapamide—Discomfort—Doxorubicin—testicular cancer	0.000403	0.000445	CcSEcCtD
Indapamide—Anorexia—Epirubicin—testicular cancer	0.000403	0.000444	CcSEcCtD
Indapamide—Dyspnoea—Methotrexate—testicular cancer	0.000402	0.000444	CcSEcCtD
Indapamide—Somnolence—Methotrexate—testicular cancer	0.000401	0.000443	CcSEcCtD
Indapamide—Dry mouth—Doxorubicin—testicular cancer	0.000399	0.00044	CcSEcCtD
Indapamide—Dyspepsia—Methotrexate—testicular cancer	0.000397	0.000439	CcSEcCtD
Indapamide—Hypotension—Epirubicin—testicular cancer	0.000395	0.000436	CcSEcCtD
Indapamide—Decreased appetite—Methotrexate—testicular cancer	0.000392	0.000433	CcSEcCtD
Indapamide—Oedema—Doxorubicin—testicular cancer	0.000391	0.000431	CcSEcCtD
Indapamide—Anaphylactic shock—Doxorubicin—testicular cancer	0.000391	0.000431	CcSEcCtD
Indapamide—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00039	0.00043	CcSEcCtD
Indapamide—Fatigue—Methotrexate—testicular cancer	0.000389	0.000429	CcSEcCtD
Indapamide—Infection—Doxorubicin—testicular cancer	0.000388	0.000429	CcSEcCtD
Indapamide—Pain—Methotrexate—testicular cancer	0.000386	0.000426	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000385	0.000425	CcSEcCtD
Indapamide—Shock—Doxorubicin—testicular cancer	0.000385	0.000424	CcSEcCtD
Indapamide—Nervous system disorder—Doxorubicin—testicular cancer	0.000383	0.000423	CcSEcCtD
Indapamide—Thrombocytopenia—Doxorubicin—testicular cancer	0.000383	0.000422	CcSEcCtD
Indapamide—Insomnia—Epirubicin—testicular cancer	0.000382	0.000422	CcSEcCtD
Indapamide—Tachycardia—Doxorubicin—testicular cancer	0.000381	0.000421	CcSEcCtD
Indapamide—Skin disorder—Doxorubicin—testicular cancer	0.00038	0.000419	CcSEcCtD
Indapamide—Paraesthesia—Epirubicin—testicular cancer	0.000379	0.000419	CcSEcCtD
Indapamide—Hyperhidrosis—Doxorubicin—testicular cancer	0.000378	0.000417	CcSEcCtD
Indapamide—Dyspnoea—Epirubicin—testicular cancer	0.000377	0.000416	CcSEcCtD
Indapamide—Somnolence—Epirubicin—testicular cancer	0.000376	0.000414	CcSEcCtD
Indapamide—Anorexia—Doxorubicin—testicular cancer	0.000373	0.000411	CcSEcCtD
Indapamide—Feeling abnormal—Methotrexate—testicular cancer	0.000372	0.000411	CcSEcCtD
Indapamide—Dyspepsia—Epirubicin—testicular cancer	0.000372	0.00041	CcSEcCtD
Indapamide—Gastrointestinal pain—Methotrexate—testicular cancer	0.000369	0.000407	CcSEcCtD
Indapamide—Decreased appetite—Epirubicin—testicular cancer	0.000367	0.000405	CcSEcCtD
Indapamide—Hypotension—Doxorubicin—testicular cancer	0.000365	0.000403	CcSEcCtD
Indapamide—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000365	0.000402	CcSEcCtD
Indapamide—Fatigue—Epirubicin—testicular cancer	0.000364	0.000402	CcSEcCtD
Indapamide—Pain—Epirubicin—testicular cancer	0.000361	0.000399	CcSEcCtD
Indapamide—Constipation—Epirubicin—testicular cancer	0.000361	0.000399	CcSEcCtD
Indapamide—Urticaria—Methotrexate—testicular cancer	0.000359	0.000396	CcSEcCtD
Indapamide—Abdominal pain—Methotrexate—testicular cancer	0.000357	0.000394	CcSEcCtD
Indapamide—Body temperature increased—Methotrexate—testicular cancer	0.000357	0.000394	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000356	0.000393	CcSEcCtD
Indapamide—Insomnia—Doxorubicin—testicular cancer	0.000354	0.00039	CcSEcCtD
Indapamide—Paraesthesia—Doxorubicin—testicular cancer	0.000351	0.000387	CcSEcCtD
Indapamide—Dyspnoea—Doxorubicin—testicular cancer	0.000348	0.000385	CcSEcCtD
Indapamide—Feeling abnormal—Epirubicin—testicular cancer	0.000348	0.000384	CcSEcCtD
Indapamide—Somnolence—Doxorubicin—testicular cancer	0.000347	0.000383	CcSEcCtD
Indapamide—Gastrointestinal pain—Epirubicin—testicular cancer	0.000345	0.000381	CcSEcCtD
Indapamide—Dyspepsia—Doxorubicin—testicular cancer	0.000344	0.00038	CcSEcCtD
Indapamide—Decreased appetite—Doxorubicin—testicular cancer	0.00034	0.000375	CcSEcCtD
Indapamide—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000337	0.000372	CcSEcCtD
Indapamide—Fatigue—Doxorubicin—testicular cancer	0.000337	0.000372	CcSEcCtD
Indapamide—Urticaria—Epirubicin—testicular cancer	0.000336	0.00037	CcSEcCtD
Indapamide—Constipation—Doxorubicin—testicular cancer	0.000334	0.000369	CcSEcCtD
Indapamide—Pain—Doxorubicin—testicular cancer	0.000334	0.000369	CcSEcCtD
Indapamide—Abdominal pain—Epirubicin—testicular cancer	0.000334	0.000369	CcSEcCtD
Indapamide—Body temperature increased—Epirubicin—testicular cancer	0.000334	0.000369	CcSEcCtD
Indapamide—Hypersensitivity—Methotrexate—testicular cancer	0.000333	0.000367	CcSEcCtD
Indapamide—Asthenia—Methotrexate—testicular cancer	0.000324	0.000357	CcSEcCtD
Indapamide—Feeling abnormal—Doxorubicin—testicular cancer	0.000322	0.000355	CcSEcCtD
Indapamide—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00032	0.000353	CcSEcCtD
Indapamide—Pruritus—Methotrexate—testicular cancer	0.000319	0.000352	CcSEcCtD
Indapamide—Hypersensitivity—Epirubicin—testicular cancer	0.000311	0.000343	CcSEcCtD
Indapamide—Urticaria—Doxorubicin—testicular cancer	0.000311	0.000343	CcSEcCtD
Indapamide—Abdominal pain—Doxorubicin—testicular cancer	0.000309	0.000341	CcSEcCtD
Indapamide—Body temperature increased—Doxorubicin—testicular cancer	0.000309	0.000341	CcSEcCtD
Indapamide—Diarrhoea—Methotrexate—testicular cancer	0.000309	0.000341	CcSEcCtD
Indapamide—Asthenia—Epirubicin—testicular cancer	0.000303	0.000334	CcSEcCtD
Indapamide—Pruritus—Epirubicin—testicular cancer	0.000299	0.00033	CcSEcCtD
Indapamide—Dizziness—Methotrexate—testicular cancer	0.000299	0.000329	CcSEcCtD
Indapamide—Diarrhoea—Epirubicin—testicular cancer	0.000289	0.000319	CcSEcCtD
Indapamide—Hypersensitivity—Doxorubicin—testicular cancer	0.000288	0.000318	CcSEcCtD
Indapamide—Vomiting—Methotrexate—testicular cancer	0.000287	0.000317	CcSEcCtD
Indapamide—Rash—Methotrexate—testicular cancer	0.000285	0.000314	CcSEcCtD
Indapamide—Dermatitis—Methotrexate—testicular cancer	0.000284	0.000314	CcSEcCtD
Indapamide—Headache—Methotrexate—testicular cancer	0.000283	0.000312	CcSEcCtD
Indapamide—Asthenia—Doxorubicin—testicular cancer	0.00028	0.000309	CcSEcCtD
Indapamide—Dizziness—Epirubicin—testicular cancer	0.000279	0.000308	CcSEcCtD
Indapamide—Pruritus—Doxorubicin—testicular cancer	0.000277	0.000305	CcSEcCtD
Indapamide—Vomiting—Epirubicin—testicular cancer	0.000269	0.000296	CcSEcCtD
Indapamide—Nausea—Methotrexate—testicular cancer	0.000268	0.000296	CcSEcCtD
Indapamide—Diarrhoea—Doxorubicin—testicular cancer	0.000267	0.000295	CcSEcCtD
Indapamide—Rash—Epirubicin—testicular cancer	0.000266	0.000294	CcSEcCtD
Indapamide—Dermatitis—Epirubicin—testicular cancer	0.000266	0.000294	CcSEcCtD
Indapamide—Headache—Epirubicin—testicular cancer	0.000265	0.000292	CcSEcCtD
Indapamide—Dizziness—Doxorubicin—testicular cancer	0.000258	0.000285	CcSEcCtD
Indapamide—Nausea—Epirubicin—testicular cancer	0.000251	0.000277	CcSEcCtD
Indapamide—Vomiting—Doxorubicin—testicular cancer	0.000249	0.000274	CcSEcCtD
Indapamide—Rash—Doxorubicin—testicular cancer	0.000246	0.000272	CcSEcCtD
Indapamide—Dermatitis—Doxorubicin—testicular cancer	0.000246	0.000272	CcSEcCtD
Indapamide—Headache—Doxorubicin—testicular cancer	0.000245	0.00027	CcSEcCtD
Indapamide—Nausea—Doxorubicin—testicular cancer	0.000232	0.000256	CcSEcCtD
